Inventor · disambiguated record
Haisheng Wang
Also filed as: WANG HAISHENG
29 granted patents·15 pending applications·1,156 citations·filing 1995–2025
98Inventor score
Files withINCYTE CORP26RODGERS JAMES D5INCYTE HOLDINGS CORP4BRISTOL MYERS SQUIBB CO1BRISTOL MYERS SQUIBB PHARMA1
Top patents by PatentIndex Score
44 records- 0199US8445488B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2011·Granted May 21, 2013·98 cites·9 claims
- 0299US8053433B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitorsINCYTE CORP·Filed 2007·Granted Nov 8, 2011·107 cites·15 claims
- 0399US7335667B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2005·Granted Feb 26, 2008·149 cites·38 claims
- 0498US9090611B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jul 28, 2015·60 cites·32 claims
- 0598US8741895B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2013·Granted Jun 3, 2014·84 cites·32 claims
- 0698US8716303B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted May 6, 2014·109 cites·74 claims
- 0798US8415362B2Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2008·Granted Apr 9, 2013·117 cites·21 claims
- 0898US8410265B2Processes for preparing JAK inhibitors and related intermediate compoundsZHOU JIACHENG·Filed 2010·Granted Apr 2, 2013·136 cites·4 claims
- 0997US9334274B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted May 10, 2016·57 cites·34 claims
- 1096US10975085B2Process for preparing a composition comprising an enantiomeric excess of greater than or equal to 90% of the (R)-enantiomer of a compound of formula IIIINCYTE HOLDINGS CORP·Filed 2019·Granted Apr 13, 2021·5 cites·8 claims
- 1196US10364248B2Processes for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidineINCYTE HOLDINGS CORP·Filed 2018·Granted Jul 30, 2019·5 cites·13 claims
- 1296US9777003B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2016·Granted Oct 3, 2017·25 cites·24 claims
- 1396US9309246B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Apr 12, 2016·33 cites·32 claims
- 1496US9249145B2Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted Feb 2, 2016·45 cites·56 claims
- 1595US11780840B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Oct 10, 2023·4 cites·12 claims
- 1695US11091484B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2019·Granted Aug 17, 2021·8 cites·21 claims
- 1795US10442803B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2017·Granted Oct 15, 2019·17 cites·29 claims
- 1895US9908888B2Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidinesINCYTE HOLDINGS CORP·Filed 2016·Granted Mar 6, 2018·6 cites·8 claims
- 1994US9580419B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2015·Granted Feb 28, 2017·10 cites·7 claims
- 2093US9879010B2Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b] pyrimidin-5-yl-amines as Janus kinase inhibitorsINCYTE CORP·Filed 2017·Granted Jan 30, 2018·8 cites·15 claims
- 2184US11352340B2Pyridine and pyridimine compounds as PI3K-gamma inhibitorsINCYTE CORP·Filed 2019·Granted Jun 7, 2022·3 cites·22 claims
- 2283US12187725B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2023·Granted Jan 7, 2025·0 cites·42 claims
- 2381US2025320212A1Tricyclic urea compounds as jak2 v617f inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2480US5985867AIndazoles of cyclic ureas useful as HIV protease inhibitorsDU PONT PHARM CO·Filed 1998·Granted Nov 16, 1999·55 cites·15 claims
- 2578US2025340559A1Processes for preparing jak inhibitors and related intermediate compoundsINCYTE HOLDINGS CORP·Filed 2025·Application pending·0 cites
- 2677US2023043959A1Piperidin-4-yl azetidine derivatives as jak1 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 2776US2025325660A1Immunomodulator compounds and methods of useINCYTE CORP·Filed 2025·Application pending·0 cites
- 2874US11952367B2Pyridine and pyridimine compounds as PI3K-gamma inhibitorsINCYTE CORP·Filed 2022·Granted Apr 9, 2024·0 cites·29 claims
- 2970US6809109B22, 4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 26, 2004·4 cites·25 claims
- 3070US2025206734A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3170US2023226062A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 3267US2025084063A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3364US2020397893A1Immunomodulator compounds and methods of useINCYTE CORP·Filed 2020·Application pending·0 cites
- 3462US6462037B11,4-benzodiazepin-2-ones useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Oct 8, 2002·2 cites·33 claims
- 3561US2009215766A1Tetracyclic inhibitors of janus kinasesINCYTE CORP·Filed 2008·Application pending·0 cites
- 3657US2018177784A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 3753US2006106020A1Tetracyclic inhibitors of Janus kinasesRODGERS JAMES D·Filed 2005·Application pending·0 cites
- 3852US2017190689A1Pyridine and pyridimine compounds as pi3k-gamma inhibitorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 3950US2004002498A1Tricyclic compounds useful as HIV reverse transcriptase inhibitorsFiled 2003·Application pending·0 cites
- 4048US2016311791A1Novel tricyclic calcium sensing receptor antogonists for the treatment of osteopososisMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 4144US2013137681A1HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORSINCYTE CORP·Filed 2013·Application pending·0 cites
- 4242US6969721B2Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA·Filed 2003·Granted Nov 29, 2005·0 cites·12 claims
- 4337US5951966ACompound toothpaste and a method of making itFiled 1995·Granted Sep 14, 1999·9 cites·19 claims
- 4431US6596729B2Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitorsSQUIBB BRISTOL MYERS PHARMA CO·Filed 2001·Granted Jul 22, 2003·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Haisheng Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →